Ignite Creation Date:
2024-05-06 @ 7:42 PM
Last Modification Date:
2024-10-26 @ 3:12 PM
Study NCT ID:
NCT06103526
Status:
RECRUITING
Last Update Posted:
2024-03-28
First Post:
2023-10-16
Brief Title:
Immunonutrition in ERAS Protocols in Gynecologic Oncology
Sponsor:
National and Kapodistrian University of Athens
Organization:
National and Kapodistrian University of Athens
Study Overview
Official Title:
Immunonutrition and Enhanced Recovery After Surgery Protocols in Gynecologic Oncology
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NUTRIGO
Brief Summary:
A patient with oncological pathology of any type because of impaired digestion and nutrient absorption decreased intake and increased nutrition requirements has an increased risk of malnutrition and moderate to severe weight lossIn the present study the investigators will evaluate the impact of perioperative immunonutrition supplementation on the postoperative outcomes
Detailed Description:
Malnutrition has a major effect not only on the postoperative course of cancer surgery but can also complicate or even limit administration or compromise the effectiveness of other treatments such as chemotherapy or radiotherapy in the perioperative period Immunonutrition is a type of artificial nutrition based on the use of some types of macro- or micronutrientsThe purpose of this review was to evaluate the use indications and effects of these formulas in oncologic surgical patients in real time and to identify the types of patients who can benefit from enteral immunonutrition
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None